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We recently reported (1, 2) that cytotoxic T  lymphocytes (CTL) with specificity for 
Qa-l-assoeiated  determinants are generated when spleen cells from mice immunized 
with H-2-identical, but Qa-l-disparate,  lymphoid cells are restimulated in vitro with 
Qa-l-disparate cells. Similar data have now been independently obtained from several 
laboratories (3-6). The most notable feature of such cytotoxic reactions, in contrast 
with  CTL  responses  to  other  minor  histocompatibility  antigens  (7),  is  that  H-2 
homology between effector and target cells in the cytotoxicity assay is not required 
(1-6). CTL responses directed against  Qa-la-associated  determinants are specifically 
blocked  by  addition  of anti-Qa-1  antiserum  to  effector-target  cell  mixtures  (2). 
Moreover, although Qa-lb-eneoded  antigens have not yet been serologically defined, 
CTL responses are readily obtained in the Qa-I a anti-Qa-1 n direction (2). 
In no instance have we or others previously noted primary in vitro CTL responses 
directed against antigenic determinants encoded within the Qa-Tla interval (2, 8, 9). 
As a result of the Qa-1  antigenic disparity of the strains involved, however, we were 
intrigued  by  the  observation  of Botzenhardt,  et  al.  (10),  recently  confirmed  by 
Theofilopoulos, et al.  (11), that CTL responses were obtained in primary cultures of 
NZB splenoeytes stimulated in vitro with H-2-identical BALB/c lymphoid cells. In 
neither  report  was  the  antigenic  target  of these  responses  identified,  nor was  the 
question of possible H-2 restrictions on these reactions clearly resolved. In this paper 
we explore the antigenic specificity of such primary CTL responses of NZB lympho- 
cytes stimulated  with  H°2-identical  lymphoid  cells.  We provide evidence that  the 
major antigenic determinants recognized in these circumstances are those associated 
with the Qa-1 b genotype. These observations thus also constitute the initial report of 
a primary in vitro immune response to antigens of the Qa-Tla system. 
Materials and Methods 
d  Mice.  NZB/N mice (H-2  , Qa-1  ~) were provided by Dr. D. P. Huston, National Institutes 
of Health, Bethesda, Md. BALB/e mice (H-2 a, Qa-1  b) were obtained from the Department of 
b  a  b  Cell Biology, Baylor College of Medicine, Houston, Tex. A-Tla  mice (H-2  , Qa-I  ) and B6- 
a  b  a  Tla  mice (H-2 , Qa-1  ) were gifts of Dr. E. A. Boyse and Dr. F. W. Shen, Memorial Sloan- 
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FIo.  1.  (A) Primary cultures of NZB anti-BALB/c CTL were assayed for cytotoxicity against the 
51Cr-labeled concanavalin  A blasts  indicated,  (B)  Primary cultures  of BALB/e anti-NZB  CTL 
against the same target cell panel. Qa-l" targets are designated with open symbols and Qa-I  b targets 
with closed symbols. Spontaneous release values ranged from 20 to 41% and errors did not exceed 
7% of total releasable counts. 
Kettering Cancer Center, New York.  Mice of the following strains were obtained from The 
Jackson Laboratory, Bar Harbor, Maine, or were bred in our animal facilities from Jackson 
Laboratory breeding trios: A/J (H-2 a, Qa-l~); B10.A (H-2 ~, Qa-la); C57BL/6  (B6, H-2 b, Qa- 
b  d  b  k  a  k  b  s  a  1  ); B10.D2 (H-2  , Qa-I  ); B10.BR (H-2  , Qa-I  ); CBA/J (H-2  , Qa-I  ); SJL (H-2, Qa-I  ); 
A.SW (H-2 s, Qa-lb); SWR (H-2 q, Qa-la); and DBA/1  (H-2 q, Qa-lb). All mice used as donors 
of responder and stimulator cells were sex-matched. Responder cells were obtained from mice 
5-10 wk of age. 
In  Vitro Generation of CTL.  CTL were generated as previously described (1,  12)~ Except as 
noted, responder spleen cells were obtained from unimmunized mice. Briefly, 6 ×  10  responder 
cells were cocuhured with  1 ×  10  e irradiated H-2-identical stimulator cells for 6  d  in 2  ml 
Eagle's minimal essential medium supplemented with fetal calf serum and 2-mercaptoethanol. 
Target  cells  were  prepared  from  concanavalin  A-stimulated blast  cells  and  labeled  with 
Naz[5]Cr]O4,  as previously described (12). 3-h 51Cr-release  assays for cell-mediated lympholysis 
were  performed at  various effector to  target  cell ratios, adjusted for viable cells. Data  are 
expressed as: 
percentage of net 5ZCr release =  experimental release -  spontaneous release ×  100. 
freeze-thaw -  spontaneous release 
Results and  Discussion 
To  evaluate the  antigenic specificity of CTL  generated  in  cultures  of unprimed 
NZB responder splenocytes and H-2-identical BALB/c stimulator cells, cultures were 
harvested  after 6  d  of incubation  and  tested  for  CTL  activity on  a  panel  of 5ZCr- 
labeled target cells (Fig.  1 A). Two qualitatively distinguishable groups of target cells 
were identified, those that were lysed and those that were not. Moreover, there was no 
apparent H-2 restriction on this cytotoxic reaction, despite the fact that the response 
was directed against non-H-2 antigenic determinants. Thus, one of the two targets of 
each  haplotype  pair, H-2 q, H-2 °,  and  H-2 k,  was  lysed.  Nevertheless,  the  antigenic 
target  of this  response  is  strongly suggested,  because  all targets  sharing  the  Qa-1 b 
genotype with BALB/c were lysed, whereas Qa-1 a targets were not. The results with 
target cells from the congenic strain pair B6 and B6-Tla a are particularly informative. 
Because  these  mice  are  genetically identical  both  within  H-2  and  for  background 
genes, and differ only by the insertion of an A  strain chromosomal segment in the Qa- RICH ET AL.  BRIEF  DEFINITIVE REPORT  1557 
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FiG. 2.  (A) Primary cultures of NZB anti-BALB/c CTL were assayed for cytotoxicity  against the 
51Cr-labeled concanavalin A blasts indicated. Spontaneous release values ranged from 27 to 45% 
and errors did not exceed 6% of total releasable counts. (B) CTL responses of NZB mice primed 3 
wk previously by injection with 5 ×  107  BALB/c spleen cells i.p. and  then cocultured with 
irradiated BALB/c cells for 6 d in vitro. Spontaneous release values ranged from 27 to 46% and 
errors did not exceed 5% of total releasable  counts. In both panels, Qa-1" targets are designated with 
open symbols  and Qa-I  b targets with closed symbols. 
Tla interval, this target cell pair maps the gene encoding this cytotoxic antigen to that 
interval. Serologically identified determinants of the Qa-TL system other than Qa-1 
seem unlikely to be involved in this response for several reasons: the strain distribution 
of target cell lysis is compatible only with Qa-1  (13); NZB and BALB/c do not differ 
for Qa-2or Qa-3 (13); C57BL/6 and B6-Tla a do not differ at Qa-2, Qa-3, Qat-4, or Qat- 
5  (13,  14);  and TL antigens have not been recognized on peripheral lymphoid cells 
(15,  16).  As previously noted, primary in vitro anti-Qa-1  reactions are not observed 
with cells from most mouse strains. Fig.  1 B thus demonstrates that a significant Qa-1- 
associated cytotoxic reaction was not observed in the reverse direction  (i.e., BALB/c 
responder cells and NZB stimulator cells). 
The foregoing experiment strongly suggests that a  primary Qa-ln-associated  cyto- 
toxic  reaction  develops  when  NZB  lymphocytes  are  stimulated  in  vitro  with 
BALB/c ceils;  it does not evaluate the possible concomitant generation of cytotoxic 
responses against  other cell surface determinants,  such  as minor histocompatibility 
antigens or viral antigens, because the H-2 homology between effector and target cells 
required  for recognition  of such  responses was  not  provided  (6,  12).  Employing a 
second panel of 5XCr-labeled target cells, the data in Fig. 2 A investigate this possibility. 
Several points are readily apparent: first, utilizing several strains different from those 
shown  in  Fig.  1, two groups of target cells were again distinguished.  The cytotoxic 
reaction was again independent of H-2 haplotypes, but correlated perfectly with the 
Qa-1  type  (Qa-1 b target  cells were  lysed;  Qa-1 ~ target  cells  were  not);  second,  the 
congenic strain pair utilized in this experiment, A/J and A-Tla b, which  is identical 
with  A  strain  except  for a  B6  chromosomal segment  in  the  Qa-Tla  interval,  again 
provides evidence that the antigen  recognized in this reaction is, in  fact, associated 
with Qa-l-encoded  determinants.  In addition,  this strain pair also provides a  degree 
of H-2  genetic  homology  which  should  allow  recognition  of additional  reactions 
against  minor  histocompatibility  antigens  or  viral  antigens  in  NZB  anti-BALB/c 
cultures (6,  17), because H-2" target cells are H-2D a. In contrast with A-Tla b targets, 
however, A/J targets were not lysed. Thus, the data provide no evidence for generation 1558  RICH ET AL.  BRIEF  DEFINITIVE REPORT 
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FIG. 3.  Primary cultures of NZB anti-B10.D2 CTL were assayed for cytotoxicity  against the 5tCr- 
labeled concanavalin A blasts indicated. Qa-l" targets are designated with open symbols  and Qa-I  b 
targets with closed symbols. Spontaneous release values ranged from 32 to 44N and errors did not 
exceed 6% of total releasable  counts. 
of such  H-2-restricted  CTL  responses.  To  provide  assurance  that  possible  minor 
histocompatibility locus-associated killing could be observed in this particular com- 
bination  of stimulator and target cells,  NZB mice were primed by injection  of 5  × 
10  7 BALB/c splenocytes i.p., and 3 wk later, spleen cells from primed animals were 
restimulated in vitro for 6 d  with BALB/c stimulator cells (Fig. 2 B).  Because under 
these circumstances, both A-Tla b and A/J target cells were lysed, we conclude  that 
the background antigenic cross-reactivities between BALB/c and A/J, and the H-2D a 
homology  between  NZB  and  A/J  were  sufficient  to  reveal  minor  locus-specific 
cytotoxic reactions of appropriately primed NZB splenocytes. 
Fig. 3 demonstrates that BALB/c cells were not unique in stimulating primary Qa- 
1b-associated  NZB  CTL.  When  NZB  spleen  cells  were  cocuhured  with  irradiated 
B 10.D2 cells, good cytotoxic reactions were observed against both B 10.D2 and H-2 b, 
Qa-1 b B10 target cells. In contrast, the Qa-1 a target cells, B 10.A and A/J, were lysed 
minimally, if at all. By providing targets congenic with the stimulator cell strain, Fig. 
3  thus  illustrates  the  marked  difference  in  CTL responses  against  Qa-l-associated 
antigenic determinants and those with specificity for C57BL/10 minor locus antigens, 
as shown by the H-2D a homologous B10.A  target cells.  Finally,  it should  be noted 
that  in  neither  this  nor  the  preceding  experiments  were  syngeneic  NZB  targets 
significantly lysed by BALB/c-stimulated NZB effector cells. 
Mouse strains which do not develop the autoimmune diseases characteristic of NZB 
mice require presensitization in vivo for the induction of both H-2-restricted cytotoxic 
responses  to  minor  histocompatibility  antigens  (7;  D.  L.  Kastner.  Unpublished 
observations.)  and  H-2-nonrestricted  responses  to  Qa-l-associated  antigens  (I,  2). 
Nonetheless, after primary in vitro stimulation of NZB splenocytes with both Qa-I b- 
associated determinants and the numerous minor locus determinants encoded by the 
BALB/c  and  C57BL/10  backgrounds,  preferential stimulation  of Qa-lb-specific  re- 
sponses was demonstrable. Spleen cells from NZB mice thus behave in vitro as though 
they had been previously primed to Qa-l-encoded  antigens, but  not  to other minor 
histocompatibility antigens. In this respect, the data suggest a similarity between Qa- 
1 antigens  and the stronger antigens of the major histocompatibility complex. It is 
therefore  also  interesting  that  spleen  cells  from unprimed  NZB  mice display CTL RICH  ET  AL.  BRIEF  DEFINITIVE REPORT  1559 
response kinetics which resemble secondary responses when stimulated in vitro with 
H-2-disparate cells (D. P. Huston. personal communication.). 
It is not yet determined whether Qa-1  hyperreactivity is a  secondary effect of the 
autoimmune  process  in  NZB  mice or whether  it  may,  in  fact,  be  involved  in  the 
pathogenesis of the disease. It is provocative, however, that Qa-1 +, Ly-l,2,3  + T  cells 
appear to serve an important role in mediating feedback inhibitory effects for antibody 
responses (18), and that NZB mice exhibit substantial deficits in such cell populations, 
both in numbers and  in functional  activity (19).  It is probable that  the NZB anti- 
BALB/c CTL response does not reflect an autoimmune process per se, because it is 
directed against determinants specified by the Qa-1 b allele. In this context, however, 
it is interesting to note an unexplained difference in the observations of Theofilopoulos, 
et  al.  (11)  from  those  of Botzenhardt,  et  al.  (10)  and  ourselves;  i.e.,  the  former 
investigators did observe a substantial cytotoxic response of CTL harvested from NZB 
anti-BALB/c cultures for syngeneic NZB targets. 
Theofilopoulos, et al.  (11)  also reported that similar cytotoxic responses were not 
generated in spleen cell cultures of MRL/1  or BXSB mice and H-2-identical stimu- 
lator cells, despite the fact that such mice also exhibit autoimmune syndromes (20). 
Nevertheless, it seems probable, based on the target cells utilized, that if MRL/1  and 
BXSB mice are capable of primary anti-Qa-1  CTL responses, this has not yet been 
tested with an appropriate target cell panel. Such studies, currently in progress, may 
provide further insight into the pathogenesis of those murine and human autoimmune 
diseases in which defective suppressor T-cell function has been demonstrable. 
Summary 
We have shown that cytotoxic lymphocytes generated in primary cultures of NZB 
spleen cells with H-2-identical BALB/c or B10.D2 stimulator cells exhibit specificity 
for Qa-lb-associated  antigenic determinants.  This unidirectional  cytotoxicity consti- 
tutes the initial demonstration of a primary in vitro response to antigens of the Qa-Tla 
system. 'Such responses do not require H-2 homology between effector and target cells 
in the assay system. In fact, when H-2D a homologous target cells were employed there 
was  little,  if any,  evidence  for development  of primary H-2-restricted  responses  to 
minor  locus  histocompatibility  antigens  or  viral  antigens.  In  view of the  recently 
defined role of Qa-1  +, Ly-l,2,3  + cells as regulators of antibody responses, and of the 
deficiency of such cells in NZB mice, the observation of hyperreactivity for determi- 
nants of this system may be relevant to the development of autoimmunity in these 
animals. 
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